Compare Match Group Inc (MTCH) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Match Group Inc vs Revvity Inc — how do they compare? Match Group Inc trades at $36.55 (market cap $8.45B), while Revvity Inc trades at $114.92 (market cap $12.91B). The key difference: Revvity Inc is the larger of the two by market cap, and Match Group Inc pays the higher dividend (2.17%). Which is the better fit depends on your goals.
| MTCH | RVTY | |
|---|---|---|
Market Cap | $8.45B | $12.91B |
Sector | Media | Technology |
52-Week High | $41.24 | $117.75 |
52-Week Low | $28.90 | $82.26 |
Enterprise Value | $11.42B | $15.23B |
Dividend Yield | 2.17% | 0.24% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MTCH trades at $36.73, down 1.42% amid mixed technical signals and recent earnings volatility. The stock shows bearish momentum with key support at $35, while fundamentals reveal strong profitability with 74.8% gross margins and 20.17% net income margin. Recent Q2 2026 earnings missed revenue estimates despite Tinder engagement improvements, creating investor uncertainty about near-term growth.
MTCH presents a value opportunity with attractive P/E of 13.05 and analyst consensus target of $42.33 (15% upside), but faces execution risks in Tinder's turnaround and high debt load. The 53% buy rating reflects optimism for Hinge growth and margin expansion, though quarterly volatility requires careful monitoring of user trends and competitive pressures.
RVTY trades at $115.18, down 0.72% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company reported strong Q2 2026 earnings of $1.41 per share, beating estimates, and raised its full-year outlook, driven by diagnostics strength and AI-enabled drug discovery. Revenue for 2025 was $2.86 billion with a net income margin of 8.16%, though valuation ratios like P/E of 55.64 appear elevated. Recent news includes product launches like the SuperFlex prenatal system and presentations at investor conferences.
The outlook is positive with analyst consensus favoring a buy rating and a $120.50 price target, suggesting upside. Key opportunities include robust diagnostics demand and innovation pipelines, while risks involve high valuation multiples and competitive pressures in the healthcare sector. Cash flow improved in 2026 to a net positive $31 million, supporting growth initiatives.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Match Group Inc
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
